Skip to content

Correlation Between Epistaxis and Cardiovascular Disease

Epistaxis Correlate With Cardiovascular Disease?

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02677467
Acronym
CBECD
Enrollment
50
Registered
2016-02-09
Start date
2016-03-31
Completion date
2016-08-31
Last updated
2016-02-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiovascular Disease, Epistaxis

Brief summary

Investigators examine blood-pressure variance, several cardiovascular risk factors of patient with epistaxis. As a result of collected data, investigators look into correlation between epistaxis and hypertensive cardiovascular disorder.

Detailed description

This study is prospective observational single blinded study. A participant is visit in the ER who patient with epistaxis. Investigators will enroll 50 patients with epistaxis. Exclusion criteria is that patient needs immediately treatment for hypertensive urgency or patient with nasal trauma. Investigators examine blood-pressure (BP) at five times in Emergency Department (ED) and out-patient department (opd) of Otorhinolaryngology (OL) . Investigators explain this study and ask to write consent for participant. After proper management of epistaxis, investigators get blood sampling of the participant and, the participant has a reservation to opd of cardiovascular division of Internal Medicine (CV opd) in the hospital. When the participant visit CV opd, the participant undergo 24-hours-BP-monitoring and Pulse wave velocity (PWV). After that, the participant will be follow-up for 3 months. Investigators collect 50 data from 50 participants as a registry and analyze the data.

Interventions

BIOLOGICALBlood-pressure variability

Day to Night Blood pressure variability

Sponsors

Hanyang University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

Group A Inclusion Criteria: * age is over 18 with spontaneous epistaxis

Exclusion criteria

* they needs immediately treatment for hypertensive urgency. * they don't want to participate in this investigation. Group B Inclusion Criteria: * age is over 18 with bleeding of wound

Design outcomes

Primary

MeasureTime frame
Cholesterol level in each group1 day
BP variability level in each group1 day
Pulse wave velocity in each group1 day

Secondary

MeasureTime frameDescription
Smoking History in each group1 dayExample = 12 pack-year
Body Mass Index in each group1 day

Countries

South Korea

Contacts

Primary ContactYOONJE LEE, M.D.
yong0831@naver.com+82-31_560-2053
Backup ContactCHANGSUN KIM, M.D., Ph.D.
flyes98@naver.com+82-31-560-2057

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026